Michael Mano insider trades: Karyopharm Therapeutics (KPTI) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | KPTI | ↓ Sell | 266 | $9.50 | $3K | Direct | May 15, 2026 (1d) |
| Sep 15, 2025 | KPTI | ↓ Sell | 234 | $6.43 | $2K | Direct | Sep 16, 2025 (1d) |
| Mar 4, 2025 | KPTI | ↓ Sell | 2,793 | $6.29 | $18K | Direct | Mar 6, 2025 (2d) |
| Sep 4, 2024 | KPTI | ↓ Sell | 3,971 | $0.72 | $3K | Direct | Sep 5, 2024 (1d) |
| Mar 1, 2024 | KPTI | ↓ Sell | 20,549 | $1.18 | $24K | Direct | Mar 4, 2024 (3d) |
| Sep 1, 2023 | KPTI | ↓ Sell | 3,888 | $1.33 | $5K | Direct | Sep 5, 2023 (4d) |
| Mar 1, 2023 | KPTI | ↓ Sell | 6,878 | $3.03 | $21K | Direct | Mar 2, 2023 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KPTI insiders
Open-market trades in the last 12 months
About Michael Mano's insider trades
Michael Mano is EVP, CLO&Secretary at Karyopharm Therapeutics (KPTI). Since Mar 1, 2023, Michael has reported no open-market purchases and 7 sales worth $75K on SEC Form 4. In the last 12 months: 1 sale ($3K).
Their filings also include grants and awards (10 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KPTI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.